Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DHAI NASDAQ:INBS NASDAQ:LYRA NASDAQ:TIVC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.27-3.1%$0.25$0.12▼$2.93$12.73M0.072.92 million shs607,156 shsINBSIntelligent Bio Solutions$1.52-1.9%$1.76$1.00▼$3.00$10.50M4.59267,231 shs77,645 shsLYRALyra Therapeutics$6.70-2.8%$10.92$3.81▼$37.50$10.71M0.1632,200 shs10,521 shsTIVCTivic Health Systems$3.16+0.6%$3.87$2.43▼$15.64$3.29M1.9831,830 shs15,814 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US0.00%+7.90%0.00%+47.72%-88.15%INBSIntelligent Bio Solutions0.00%+3.40%-16.94%+25.62%+31.03%LYRALyra Therapeutics0.00%+1.82%-26.05%+36.46%-56.24%TIVCTivic Health Systems0.00%-1.86%-25.65%-20.20%-51.28%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDHAIDIH Holding US0.9644 of 5 stars0.05.00.00.01.91.70.0INBSIntelligent Bio Solutions0.3881 of 5 stars0.03.00.00.00.60.01.3LYRALyra Therapeutics3.3328 of 5 stars3.25.00.00.01.82.51.3TIVCTivic Health SystemsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDHAIDIH Holding US 0.00N/AN/AN/AINBSIntelligent Bio Solutions 0.00N/AN/AN/ALYRALyra Therapeutics 2.33Hold$100.001,392.54% UpsideTIVCTivic Health Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDHAIDIH Holding US$64.47M0.20N/AN/A($0.80) per share-0.34INBSIntelligent Bio Solutions$3.11M3.38N/AN/A$2.37 per share0.64LYRALyra Therapeutics$1.53M7.01N/AN/A$8.86 per share0.76TIVCTivic Health Systems$780K4.21N/AN/A$4.55 per share0.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDHAIDIH Holding US-$8.44M-$0.30N/A∞N/A-13.59%N/A-25.97%N/AINBSIntelligent Bio Solutions-$10.16MN/A0.004.34N/A-319.85%-176.55%-93.89%9/17/2025 (Estimated)LYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)TIVCTivic Health SystemsN/AN/A0.00∞N/A-4.07%-0.67%-0.57%8/14/2025 (Estimated)Latest TIVC, DHAI, INBS, and LYRA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025LYRALyra Therapeutics-$5.79N/AN/AN/A$0.18 millionN/A5/15/2025Q1 2025TIVCTivic Health SystemsN/A-$2.52N/A-$2.52N/A$0.07 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDHAIDIH Holding USN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/ATIVCTivic Health SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDHAIDIH Holding USN/A0.510.34INBSIntelligent Bio SolutionsN/A1.120.97LYRALyra TherapeuticsN/A2.962.96TIVCTivic Health SystemsN/A1.701.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDHAIDIH Holding US27.76%INBSIntelligent Bio Solutions32.97%LYRALyra Therapeutics95.62%TIVCTivic Health Systems4.25%Insider OwnershipCompanyInsider OwnershipDHAIDIH Holding US49.58%INBSIntelligent Bio Solutions1.54%LYRALyra Therapeutics3.25%TIVCTivic Health Systems0.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDHAIDIH Holding USN/A47.34 million23.87 millionN/AINBSIntelligent Bio Solutions106.91 million6.80 millionNot OptionableLYRALyra Therapeutics501.60 million1.55 millionOptionableTIVCTivic Health Systems101.04 million1.04 millionNot OptionableTIVC, DHAI, INBS, and LYRA HeadlinesRecent News About These CompaniesTivic Health stock rises after shareholders approve strategic proposalsJuly 8, 2025 | in.investing.comTivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFOJuly 8, 2025 | finance.yahoo.comTivic Health Shares Gain Following Shareholder Approval of Strategic MovesJuly 8, 2025 | msn.comTivic Health Systems Inc (TIVC) - Investing.comJuly 5, 2025 | investing.comTivic Health Systems Inc News (TIVC) - Investing.comJuly 1, 2025 | investing.comTivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device - Business WireJune 26, 2025 | businesswire.comTivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation DeviceJune 25, 2025 | businesswire.comTivic Health Systems, Inc. (TIVC) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comTivic Health Announces 2025 Annual Meeting of StockholdersJune 24, 2025 | finance.yahoo.comTivic Health sets new deadlines for stockholder proposalsMay 21, 2025 | investing.comTivic Health Systems, Inc. (NASDAQ:TIVC) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comTivic Health’s Strategic Shift: Earnings Call InsightsMay 16, 2025 | tipranks.comTivic Health signals strategic transformation with $8.4M financing and biopharma focus amid market repositioningMay 16, 2025 | msn.comTivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comTivic Reports First Quarter 2025 Financial Results and Provides Updates on Business TransformationMay 15, 2025 | businesswire.comTivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA SubmissionMay 14, 2025 | finance.yahoo.comTivic adds new vagus nerve stim patentMay 13, 2025 | massdevice.comTivic Expands VNS Intellectual Property PortfolioMay 13, 2025 | businesswire.comTivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and WebcastMay 9, 2025 | businesswire.comTivic Health reports White House briefings, FDA meetings on product applicationsApril 23, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTIVC, DHAI, INBS, and LYRA Company DescriptionsDIH Holding US NASDAQ:DHAI$0.27 -0.01 (-3.06%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.27 0.00 (0.00%) As of 08/8/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.Intelligent Bio Solutions NASDAQ:INBS$1.52 -0.03 (-1.94%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.57 +0.05 (+3.29%) As of 08/8/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Lyra Therapeutics NASDAQ:LYRA$6.70 -0.19 (-2.76%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$6.56 -0.14 (-2.01%) As of 08/8/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Tivic Health Systems NASDAQ:TIVC$3.16 +0.02 (+0.64%) Closing price 08/8/2025 03:56 PM EasternExtended Trading$3.16 0.00 (0.00%) As of 08/8/2025 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
